RGC Stock — Price, Charts & Analysis

RGC's trailing EPS is -$0.01.

EPS, or earnings per share, shows how much profit Regencell Bioscience Holdings Limited generated for each share. RGC's trailing EPS is -$0.01, and investors usually prefer EPS that is positive and growing over time.

Regencell Bioscience Holdings Limited has a market cap of $2.60B, making RGC a mid-cap stock based on the current market value shown on Worldtickers.

RGC's latest stock price on Worldtickers is $5.26. The latest move is -$0.18 or -3.31%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

RGC's quote includes a latest price of $5.26. The market open is $5.44. Previous close is $5.44. The intraday range is $5.22 to $5.50.

RGC is down in the latest quote, with a move of -$0.18 or -3.31%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

No, RGC does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$7.05M.

Gross margin is 0.00%. Margins show how efficiently Regencell Bioscience Holdings Limited turns revenue into profit.

Regencell Bioscience Holdings Limited carries $386.30K and holds $2.36M in cash.

RGC holds $2.36M on its balance sheet.

RGC's book value per share is $0.00.

Institutions hold 0.29% of RGC shares. Insiders hold 88.38% of shares. Ownership mix helps investors understand how much of Regencell Bioscience Holdings Limited is held by professional investors and company insiders.

RGC has 494.49M shares outstanding. Float shares are 56.28M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for RGC, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

RGC's trailing EPS is -$0.01. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

RGC trades at $5.26. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Regencell Bioscience Holdings Limited's fundamentals.

RGC risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 1.49, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

RGC should be compared with companies in Drug Manufacturers - Specialty & Generic. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Regencell Bioscience Holdings Limited (RGC) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

RGC trades on NasdaqCM. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

RGC stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Regencell Bioscience Holdings Limited's official website listed on Worldtickers is www.regencellbioscience.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Regencell Bioscience Holdings Limited employs about 10 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Regencell Bioscience Holdings Limited is headquartered in Causeway Bay, Hong Kong. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

RGC is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

RGC has traded between $4.51 and $69.00 over the past 52 weeks. At $5.26, it is 92.38% below the high and 16.63% above the low. The 52-week range helps gauge long-term price momentum.

RGC is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is $7.32 and its 200-day moving average is $20.29.

RGC's RSI is 37.78. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

RGC's latest RSI reading is 37.78, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for RGC is near $4.91. Key resistance is near $6.75. Breaks above resistance or below support can change the short-term technical setup.

RGC's nearest reported support level is $4.91. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

RGC's nearest reported resistance level is $6.75. A breakout above resistance can improve momentum, especially when volume confirms the move.

RGC trades about 307.47K shares daily on average. The latest displayed volume is 103.15K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

RGC's MACD is 0.24, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

RGC is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 37.78 (neutral). MACD is bullish. Nearest support is around $4.91. Resistance is around $6.75. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $5.59 (-5.95% from price). MA50 is $7.32 (-28.13% from price). MA200 is $20.29 (-74.08% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. RGC's MA20 is $5.59. MA50 is $7.32. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

RGC's pivot is near $5.62. Support is near $4.91. Resistance is near $6.75. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for RGC is near $4.51. The next upper resistance zone is near $5.80. These levels help define risk and possible follow-through zones after a breakout or breakdown.

RGC's Bollinger range is roughly $4.90 to $6.29. Band width is near 24.80%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

RGC's ATR-based typical daily range is about 12.56%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 103.15K shares. Average volume is about 307.47K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

RGC's all-time high shown on Worldtickers is $83.60. Its all-time low is $0.08. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

RGC has a beta of 1.49, meaning it has historically been more volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.